Lyell Immunopharma reports Q2 results

* Lyell Immunopharma press release [https://seekingalpha.com/pr/20198605-lyell-immunopharma-reports-business-highlights-and-financial-results-for-the-second-quarter] (NASDAQ:LYEL [https://seekingalpha.com/symbol/LYEL]): Q2 net loss of $42.7 million
* Revenue of $8K, vs. $13K a year ago

MORE ON LYELL IMMUNOPHARMA

* Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program Advancement [https://seekingalpha.com/article/4803000-lyell-hold-rating]
* Lyell Immunopharma announces up to $100 million equity private placement [https://seekingalpha.com/news/4472134-lyell-immunopharma-announces-up-to-100-million-equity-private-placement]
* Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments [https://seekingalpha.com/news/4456705-lyell-immunopharma-strengthens-clinical-and-commercial-capabilities-with-executive-appointments]
* Seeking Alpha’s Quant Rating on Lyell Immunopharma [https://seekingalpha.com/symbol/LYEL/ratings/quant-ratings]
* Historical earnings data for Lyell Immunopharma [https://seekingalpha.com/symbol/LYEL/earnings]